Anesthesia for thymectomy in children with myasthenia gravis

Paediatric Anaesthesia

Volumn 14, Issue 8, 2004, Pages 625-635

  White, Michelle C ^b   Stoddart, Peter A ^a  

^a BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

^b NONE

Author keywords

Anesthesia; Children; Myasthenia gravis; Thymectomy

Indexed keywords

ALFENTANIL; ANESTHETIC AGENT; ATRACURIUM; ATROPINE; AZATHIOPRINE; CHOLINESTERASE INHIBITOR; FENTANYL; GLYCOPYRRONIUM BROMIDE; IMMUNOGLOBULIN G; ISOFLURANE; MORPHINE; MUSCLE RELAXANT AGENT; NEOSTIGMINE; NITROUS OXIDE PLUS OXYGEN; PREDNISOLONE; PROPOFOL; PYRIDOSTIGMINE; SEVOFLURANE; VECURONIUM;

ADOLESCENT; ANAMNESIS; ANESTHESIA; ANESTHESIOLOGICAL TECHNIQUES; BULBAR PARALYSIS; CASE REPORT; CLINICAL FEATURE; COUGHING; DOSE RESPONSE; DOSE TIME EFFECT RELATION; ENDOTRACHEAL INTUBATION; FEMALE; HUMAN; INTERMITTENT POSITIVE PRESSURE VENTILATION; LARYNGEAL MASK; LUNG FUNCTION TEST; MYASTHENIA GRAVIS; NAUSEA AND VOMITING; PATIENT CONTROLLED ANALGESIA; PEDIATRIC ANESTHESIA; PLASMAPHERESIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD; STERNOTOMY; THYMECTOMY;

ADOLESCENT; ANESTHESIA; ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; CHILD; FEMALE; HUMANS; MYASTHENIA GRAVIS; NEUROMUSCULAR NONDEPOLARIZING AGENTS; THYMECTOMY;

EID: 4043165625     PISSN: 11555645     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2004.01292.x     Document Type: Review

References (53)

1. Drachman DB. Medical progress: myasthenia gravis. N Engl J Med 1994; 330: 1797-1810.
2. Baraka A. Anesthesia and critical care of thymectomy for myasthenia gravis. Chest Surg Clin N Am 2001; 11: 337-361.
3. Chevalley C, Spiliopoulos A, de Perrot M et al. Perioperative medical management and outcome following thymectomy for myasthenia gravis. Can J Anaesth 2001; 48: 446-451.
4. Stevens RD. Neuromuscular disorders and anesthesia. Current opinion in Anaesthesiology 2001; 14: 693-698.
5. Baraka AS, Jalbout MI. Anesthesia and myopathy. Current opinion in Anaesthesiology 2002; 15: 371-376
6. Thavasothy M, Hirsch N. Myasthenia gravis. Br J Anaesth CEPD Rev 2002; 2: 88-90
7. Brown TCK, Gerbert R, Meretoja OA et al. Myasthenia gravis in children and its anaesthetic implications. Anaesth Intens Care 1990; 18: 466-472.
8. Davies DW, Steward DJ. Myasthenia gravis in children and anaesthetic management for thymectomy. Canad Anaesth Soc J 1973; 20: 253-258.
9. Fonkalsrud EW, Herrmann C Jr, Mulder DG. Thymectomy for myasthenia gravis in children. J Pediatr Surg 1970; 5: 157-165.
10. Andrews PI, Massey JM, Howard JF Jr et al. Race, sex, and puberty influence onset, severity, and outcome in juvenile myasthenia gravis. Neurology 1994; 44: 1208-1214.
11. McCreery KMB, Hussein MAW, Lee AG et al. Major review: the clinical spectrum of pediatric myasthenia gravis: blepharoptosis, opthalmoplegia and strabismus. A report of 14 cases. Binoc Vis Strabismus 2002; 17: 181-186.
12. Lindner A, Schalke B, Toyka KV. Outcome in juvenile-onset myasthenia gravis: a retrospective study with long term follow-up of 79 patients. J Neurol 1997; 244: 515-520.
13. Batocchi AP, Evoli A, Palmisani MT et al. Early-onset myasthenia gravis: clinical characteristics and response to therapy. Eur J Pediatr 1990; 150: 66-68.
14. Snead OC, Kohaut EC, Oh SJ et al. Plasmapheresis for myasthenic crisis in a young child. J Pediatr 1987; 110: 740-742.
15. Anlar B. Juvenile myasthenia: diagnosis and treatment. Paediatr Drugs 2000; 2: 161-169.
16. King JM, Hunter JM. Physiology of the neuromuscular junction. Br J Anaesth CEPD Reviews 2002; 2: 129-133.
17. Andrews PI, Massey JM, Sanders DB. Acetycholine receptor antibodies in juvenile myasthenia gravis. Neurology 1993; 43: 977-982.
18. Adams C, Theodorescu D, Murphy EG et al. Thymectomy in juvenile myasthenia gravis. J Child Neurol 1990; 5: 215-218.
19. Kogut KA, Bufo AJ, Rothenberg SS et al. Thoracoscopic thymectomy for myasthenia gravis in children. J Pediatr Surg 2000; 35: 1576-1577.
20. Kas J, Kiss D, Simon V et al. Decade-long experience with surgical therapy of myasthenia gravis: early complications of 324 transsternal thymectomies. Ann Thorac Surg 2001; 72: 1691-1697.
21. Anlar B, Ozidirim E. Thymectomy in children with myasthenia gravis [letter]. Neuropediatrics 1999; 30: 49.
22. Ramelli GP, Sturzenegger M, Bianchetti MG et al. Thymectomy in children with generalised myasthenia gravis [letter]. Neuropediatrics 1997; 28: 292.
23. Eisenkraft JB, Book J, Mann SM et al. Resistance to succinylcholine in myasthenia gravis: a dose-response study. Anesthesiology 1988; 69: 760.
24. Baraka A, Baroody M, Yazbeck V. Repeated doses of suxamethonium in the myasthenic patient. Anaesthesia 1993; 48: 782.
25. Baraka A. Suxamethonium block in the myasthenic patient: correlation with plasma cholinesterase. Anaesthesia 1992; 47: 217.
26. Baraka A. Onset of neuromuscular block in myasthenia patients. Br J Anaesth 1992; 69: 227-228.
27. Bell CF, Florence AM, Hunter JM et al. Atracurium in the myasthenic patient. Anaesthesia 1984; 39: 961-968.
28. Mann R, Blobner M, Jelen-Esselborn S et al. Preanaesthetic train-of-four fade predicts the atracurium requirement of myasthenia gravis patients. Anesthesiology 2000; 93: 364-350.
29. Itoh H, Shibata K, Nitta S. Difference in sensitivity to vecuronium between patients with ocular and generalized myasthenia gravis. Br J Anaesth 2001; 87: 885-889.
30. Nilsson E, Meretoja OA. Vecuronium dose-response and maintenance requirements in patients with myasthenia gravis. Anesthesiology 1990; 73: 28-32.
31. Baraka A, Taha S, Yazbeck V et al. Vecuronium block in the myasthenic patient: influence of anticholinesterase therapy. Anaesthesia 1993; 48: 588-590.
32. Fisher DM, Canfell C, Spellman MJ et al. Pharmacokinetics and pharmacodynamics of atracurium in infants and children. Anesthesiology 1990; 73: 33-37.
33. Baraka A, Dajani A. Atracurium in myasthenics undergoing thymectomy. Anesth Analg 1984; 63: 1127-1130.
34. Paterson IG, Hood JR, Russell SH et al. Mivacurium in the myasthenic patient. Br J Anaesth 1994; 73: 494-498.
35. De Haes A, Proost JH, Kuks JBM et al. Pharmacokinetics/pharmacodynamic modeling of rocuronium in myasthenic patients is improved by taking into account the number of unbound acetylcholine receptors. Anesth Analg 2000; 95: 588-596.
36. Baraka A, Siddik S, Kawkabani N. Cisatracurium in a myasthenic patient undergoing thymectomy. Can J Anaesth 1999; 46: 779.
37. Epstein RA, Jackson SH. The effect of depth of anesthesia on the neuromuscular refactory: a model of myasthenia gravis. Science 1975; 187: 955-957.
38. Gissen AJ, Karis JH, Nastuk WL. Effect of halothane on neuromuscular transmission. JAMA 1966; 1: 197-199.
39. Katz RL, Gissen AJ. Neuromuscular and electromyographic effects of halothane and its interaction with d-tubocurare in man. Anesthesiology 1967; 28: 564-567.
40. Rowbottom SJ. Isoflurane for thymectomy in myasthenia gravis. Anaesth Intensive Care 1989; 17: 444-447.
41. Nilsson E, Muller K. Neuromuscular effects of isoflurane in patients with myasthenia gravis. Acta Anaesthesiol Scan 1990; 34: 126-131.
42. Itoh H, Shibata K. Comparison between sevoflurane and propofol neuromuscular effects in patient with myasthenia gravis: effective doses of vecuronium. Anesthesiology 2001; 95: 803-805.
43. Kiran U, Choudhury M, Saxena N et al. Sevoflurane as a sole anaesthetic for thymectomy in myasthenia gravis. Acta Anaesthesiol Scand 2000; 44: 351-353.
44. Hubler M, Litz RJ, Albrecht DM. Combination of balanced and regional anaesthesia for minimally invasive surgery in a patient with myasthenia gravis. Eur J Anaesthiol 2000; 17: 325-328.
45. Chevalley C, Spiliopoulos A, de Perrot M et al. Perioperative medical management and outcome following thymectomy for myasthenia gravis. Can J Anaesth 2000; 48: 446-451.
46. Rosow C. Remifentanil: a unique opioids analgesic. Anesthesiology 1993; 79: 875-876.
47. Lorimer M, Hall R. Remifentanil and propofol total intravenous anaesthesia for thymectomy in myasthenia gravis. Anaesth Intensive Care 1998; 26: 210-212.
48. Lin TC, Hsu CH, Kong SS et al. Ventricular asystole and complete heart block after thoracic epidural analgesia for thymectomy. Eur J Anaesthesiol 2002; 19: 460-462.
49. Kluger MT, Bullock MFM. Recovery room incidents: a review of 419 reports from the Anaesthetic Monitoring Study (AIMS). Anaesthesia 2002; 57: 1060-1066.
50. Hughes S, Griffiths R. Anaesthesia monitoring techniques. Anaesth Intensive Care Med 2002; 3: 477-480.
51. Kopman AF. Measurement and monitoring of neuromuscular blockade. Curr Opin Anaesthesiol 2002; 15: 415-420.
52. Itoh H, Shibata K, Yoshida M et al. Neuromuscular monitoring at the orbicularis oculi may overestimate the blockade in myasthenic patients. Anesthesiology 2000; 93: 1194-1197
53. Briassoulis G, Hatzis T, Liakopoulou T et al. Continuous neostigmine infusion in post-thymectomy juvenile myasthenic crisis. J Child Neurol 2000; 15: 747-749.